Kalm Therapeutics
Pre-clinicalKalm Therapeutics is developing the 1st Prescription Patch treatment for eczema and psoriasis.
Founded
2018
Focus
Drug Delivery
About
Kalm Therapeutics is developing the 1st Prescription Patch treatment for eczema and psoriasis.
Funding History
2Total raised: $29.2M
Series A$25MAtlas VentureMar 15, 2023
Seed$4.2MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile